Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of Interim Results

4th Sep 2012 11:00

RNS Number : 4060L
e-Therapeutics plc
04 September 2012
 

 

  

 

Notice of Interim Results

 

 

e-Therapeutics plc (AIM: ETX), the drug discovery and development company with a proprietary platform in network pharmacology, will be announcing its interim results for the six months ended 31st July 2012 on Monday 22nd October 2012.

 

-Ends-

 

 

For more information, please contact:

 

e-Therapeutics plc

Malcolm Young / Daniel Elger

Tel: +44 (0) 7909 915 068

www.etherapeutics.co.uk 

 

Panmure Gordon (UK) Limited

Fred Walsh / Hannah Woodley / Grishma Patel

Tel: +44 (0) 20 7886 2500

www.panmure.com

 

College Hill

Melanie Toyne Sewell / Jayne Crook

Tel: +44 (0) 20 7457 2020

Email: [email protected]

 

CommStrat Group (US)

Ted Agne

Tel: (+1) 781 631 3117

Email: [email protected]

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORSSMFWDFESEIU

Related Shares:

ETX.L
FTSE 100 Latest
Value8,415.25
Change7.81